Sansure Biotech Inc. 688289.SS Stock
Sansure Biotech Inc. Price Chart
Sansure Biotech Inc. 688289.SS Financial and Trading Overview
Sansure Biotech Inc. stock price | 19.89 CNY |
Previous Close | 17.36 CNY |
Open | 17.34 CNY |
Bid | 17.33 CNY x N/A |
Ask | 17.35 CNY x N/A |
Day's Range | 17.23 - 17.41 CNY |
52 Week Range | 16.91 - 31.62 CNY |
Volume | 1.43M CNY |
Avg. Volume | 4.2M CNY |
Market Cap | 10.2B CNY |
Beta (5Y Monthly) | 0.529641 |
PE Ratio (TTM) | 7.5676856 |
EPS (TTM) | 0.66 CNY |
Forward Dividend & Yield | 1.67 (9.77%) |
Ex-Dividend Date | May 29, 2023 |
1y Target Est | N/A |
688289.SS Valuation Measures
Enterprise Value | 4.48B CNY |
Trailing P/E | 7.5676856 |
Forward P/E | 4.965616 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.9589773 |
Price/Book (mrq) | 1.3261402 |
Enterprise Value/Revenue | 0.86 |
Enterprise Value/EBITDA | 2.948 |
Trading Information
Sansure Biotech Inc. Stock Price History
Beta (5Y Monthly) | 0.529641 |
52-Week Change | -44.036% |
S&P500 52-Week Change | 20.43% |
52 Week High | 31.62 CNY |
52 Week Low | 16.91 CNY |
50-Day Moving Average | 19.88 CNY |
200-Day Moving Average | 23.12 CNY |
688289.SS Share Statistics
Avg. Volume (3 month) | 4.2M CNY |
Avg. Daily Volume (10-Days) | 2.42M CNY |
Shares Outstanding | 588.46M |
Float | 238.68M |
Short Ratio | N/A |
% Held by Insiders | 60.30% |
% Held by Institutions | 5.33% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.298 |
Trailing Annual Dividend Yield | 7.47% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.53970003 |
Last Split Factor | 1.48:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 25.83% |
Operating Margin (ttm) | 27.60% |
Gross Margin | 53.15% |
EBITDA Margin | 29.18% |
Management Effectiveness
Return on Assets (ttm) | 10.86% |
Return on Equity (ttm) | 18.46% |
Income Statement
Revenue (ttm) | 5.21B CNY |
Revenue Per Share (ttm) | 8.83 CNY |
Quarterly Revenue Growth (yoy) | -86.40% |
Gross Profit (ttm) | 3.54B CNY |
EBITDA | 1.52B CNY |
Net Income Avi to Common (ttm) | 1.34B CNY |
Diluted EPS (ttm) | 2.29 |
Quarterly Earnings Growth (yoy) | -90.79% |
Balance Sheet
Total Cash (mrq) | 5.47B CNY |
Total Cash Per Share (mrq) | 9.45 CNY |
Total Debt (mrq) | 22.48M CNY |
Total Debt/Equity (mrq) | 0.3 CNY |
Current Ratio (mrq) | 6.481 |
Book Value Per Share (mrq) | 13.068 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.89B CNY |
Levered Free Cash Flow (ttm) | 816.88M CNY |
Profile of Sansure Biotech Inc.
Country | China |
State | N/A |
City | Changsha |
Address | No. 680, Lusong Road |
ZIP | 410205 |
Phone | 86 73 1888 8317 |
Website | https://www.sansure.com.cn |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 2567 |
Sansure Biotech Inc. engages in the research and development, production, and sale of in-vitro diagnostic reagents and ancillary instruments in China. The company offers Hepatitis B virus nucleic acid detection kits, fully automatic nucleic acid extraction system, real-time fluorescent quantitative PCR analysis system, fully automatic cup and liquid processing system, mobile molecular diagnostic system, and high-throughput sequencing system. It also provides genetic testing services; next generation sequencing services; bioinformatics analysis services; and postdoctoral recruitment and scientific research cooperation services, as well as third-party medical testing services. The company was founded in 2008 and is headquartered in Changsha, China.
Q&A For Sansure Biotech Inc. Stock
What is a current 688289.SS stock price?
Sansure Biotech Inc. 688289.SS stock price today per share is 19.89 CNY.
How to purchase Sansure Biotech Inc. stock?
You can buy 688289.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sansure Biotech Inc.?
The stock symbol or ticker of Sansure Biotech Inc. is 688289.SS.
Which industry does the Sansure Biotech Inc. company belong to?
The Sansure Biotech Inc. industry is Medical Instruments & Supplies.
How many shares does Sansure Biotech Inc. have in circulation?
The max supply of Sansure Biotech Inc. shares is 588.46M.
What is Sansure Biotech Inc. Price to Earnings Ratio (PE Ratio)?
Sansure Biotech Inc. PE Ratio is 30.13636200 now.
What was Sansure Biotech Inc. earnings per share over the trailing 12 months (TTM)?
Sansure Biotech Inc. EPS is 0.66 CNY over the trailing 12 months.
Which sector does the Sansure Biotech Inc. company belong to?
The Sansure Biotech Inc. sector is Healthcare.
Stocks Related By Sector
- Tibet Cheezheng Tibetan Medicine Co., Ltd. 002287.SZ Stock
- GuangYuYuan Chinese Herbal Medicine Co., Ltd. 600771.SS Stock
- Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS Stock
- Liaoning Chengda Biotechnology Co.,Ltd. 688739.SS Stock
- Guangdong Zhongsheng Pharmaceutical Co., Ltd. 002317.SZ Stock